Clinical Trial Update: A Phase 1b Study Of Axitinib In Combination With Crizotinib In Patients With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

A Phase 1b study evaluating axitinib in combination with crizotinib in patients with advanced solid tumors has been completed, with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• Axitinib (Axitinib)
• Crizotinib (crizotinib)

Snippet

Sponsor: Pfizer | Conditions: Advanced Solid Tumors | Phase 1 | Status: COMPLETED | Results posted: 2019-06-21